Delivery Order SPE2DE24D0013-SPE2D625F9XM2
- Not listed
- The U.S. Defense Department's Medical Supply Chain division awarded a $23,475.80 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The contract, designated XPCOV2/FLU/RSV-10, was awarded on July 29, 2025, with an ultimate completion date of August 12, 2025, and carries no set-aside designation. Work will be performed at Cepheid's Sunnyvale facility. This delivery order represents procurement of diagnostic testing...
- The Defense Department's Medical Supply Chain awarded a $4,080 firm fixed-price delivery order to Cepheid Inc. on July 18, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, designated as XPCOV2/FLU/RSV-10, represents a delivery order with an ultimate completion date of July 25, 2025, and carries no set-aside designation. Work will be performed at Cepheid's facility in Sunnyvale, California. This award reflects...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $13,096.80 to Cepheid Inc. on July 28, 2025, for molecular diagnostic testing solutions. This firm fixed-price delivery order, designated 4568920464 and titled XPCOV2/FLU/RSV-10, carries an ultimate completion date of August 11, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. The contract involves diagnostic testing capabilities for COVID-19, influenza, and respiratory syncytial...
- The Defense Department's Medical Supply Chain division awarded a $3,400 firm fixed-price delivery order to Cepheid Inc. on July 30, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, designated as delivery order XPCOV2/FLU/RSV-10, is scheduled for completion by August 6, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. This award carries no set-aside designation and represents a...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain office, awarded a firm fixed-price delivery order valued at $8,840 to Cepheid Inc. on July 29, 2025, with an ultimate completion date of August 5, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions, specifically reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). The contract carries no set-aside designation and will be...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $3,400 firm fixed-price delivery order to Cepheid Inc. on August 1, 2025, with an ultimate completion date of August 8, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). Cepheid, a for-profit molecular diagnostics manufacturer headquartered in Sunnyvale, California, specializes in advanced diagnostic...
- The Defense Medical Supply Chain awarded a $4,080 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostic manufacturer headquartered in Sunnyvale, California, on July 21, 2025, with an ultimate completion date of July 28, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, carries no set-aside designation and pertains to COVID-19, influenza, and respiratory syncytial virus diagnostic solutions. The contract represents work performed under Cepheid's existing indefinite...
- The U.S. Defense department's Medical Supply Chain agency awarded a delivery order valued at $1,440 to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on July 28, 2025. This firm fixed-price delivery order, designated as 4568910320 and issued under the GXCDIFF/EPI-10 vehicle, carries an ultimate completion date of August 4, 2025, with no set-aside designation. The award represents a continuation of the federal government's procurement of Cepheid's advanced...
- The U.S. Defense Department's Medical Supply Chain awarded a $4,488 firm fixed-price delivery order to Cepheid Inc. on July 30, 2025, for SARS-CoV-2, influenza, and respiratory syncytial virus (RSV) diagnostic solutions. The delivery order, which carries an ultimate completion date of August 13, 2025, will be performed at Cepheid's headquarters in Sunnyvale, California. This award includes no set-aside designation and represents a near-term procurement from the Sunnyvale-based molecular...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $5,174.64 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, designated XPCOV2/FLU/RSV-10, has an ultimate completion date of July 30, 2025, and carries no set-aside designation. The contract references diagnostic testing for COVID-19, influenza, and respiratory syncytial virus (RSV), consistent with...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F9XM2Delivery Order
The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $2,040 to Cepheid Inc. on August 1, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order, designated 4568960200 for XPCOV2/FLU/RSV-10, carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. The delivery order designation suggests this award was issued under a larger indefinite delivery vehicle (IDV) contract, consistent with Cepheid's existing federal contract portfolio with the Department of Veterans Affairs and Defense Logistics Agency. Cepheid, a molecular diagnostics manufacturer specializing in advanced infectious disease testing solutions, will deliver products or services related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The company has established itself as a key supplier of GeneXpert diagnostic systems and associated test kits to federal healthcare agencies, with existing IDV contracts valued at over $35 million supporting ongoing procurement of molecular diagnostic reagents and assays. This modest delivery order represents continued federal reliance on Cepheid's diagnostic capabilities within the Defense Department's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/1/25 |